Clinical Trial Update: PERT in Acute Necrotizing Pancreatitis [Phase 3]

View source ↗

Summary

Phase 3 trial of pancreatic enzyme replacement therapy (PERT) for necrotizing acute pancreatitis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Pancreatitis
• Pancreatitis

Drugs mentioned

• Pancreatic enzyme replacement therapy (PERT) (pancreatic enzyme replacement therapy)

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: Acute Pancreatitis Necrotizing, Nutrition Assessment | Phase 3 | Status: NOT_YET_RECRUITING